Neutrophil Extracellular Traps (NETs) Mediated Killing of Carbapenem-resistant Pseudomonas Aeruginosa.
NCT06441708 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2024-06-04
Summary
Aim of the work:
To determine the killing ability of neutrophils to ATCC 27853, carbapenem-resistant P. aeruginosa.
To compare between the ability of ATCC 27853, carbapenem-resistant P. aeruginosa to induce NETs formation.
To quantify NETS formation in response to PMA, ATCC 27853, carbapenem-resistant P. aeruginosa using immunofluorescence.
To determine the killing ability of NETs on ATCC 27853, carbapenem-resistant P. aeruginosa.
Conditions
- Neutrophil Extracellular Traps Formation
Interventions
- OTHER
-
No intervention
No intervention on patient
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-01
- Primary Completion
- 2025-06-01
- Completion
- 2025-07-01
More Related Trials
-
Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems
NCT04876430 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Clinical and Microbiological Outcomes of Infections Due to Carbapenem-Resistant Gram-Negative Bacteria
NCT01041716 ·Status: COMPLETED
-
Early Oral Switch for Uncomplicated Gram-negative Bacteraemia
NCT05199324 ·Status: RECRUITING ·Phase: PHASE4
-
Staphylococcus Aureus Network Adaptive Platform Trial
NCT05137119 ·Status: RECRUITING ·Phase: PHASE4
-
Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection
NCT02482961 ·Status: COMPLETED
-
Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia
NCT01975662 ·Status: TERMINATED ·Phase: PHASE2
-
Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations
NCT04573894 ·Status: COMPLETED
-
Colistin Monotherapy vs Colsitin-fosfomycine in CRAB Infection
NCT06570850 ·Status: RECRUITING ·Phase: PHASE4
-
Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO
NCT02149329 ·Status: COMPLETED ·Phase: PHASE4
-
NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria
NCT05017766 ·Status: RECRUITING
-
Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection
NCT03349268 ·Status: COMPLETED ·Phase: NA
-
The Most Appropriate Parameter Correlates With Clinical Effectiveness of Vancomycin: Trough Drug Concentration or Area Under Curve (AUC)/Minimum Inhibitory Concentration (MIC)?
NCT01995760 ·Status: COMPLETED
-
Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus
NCT00175370 ·Status: COMPLETED ·Phase: NA
-
Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections
NCT06843668 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents
NCT00811980 ·Status: COMPLETED
-
Cefiderocol vs Best Available Therapy for Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex Infections: A Target Trial Emulation
NCT07226557 ·Status: ACTIVE_NOT_RECRUITING
-
The Immunostimulatory Effects of Gentamicin
NCT05303909 ·Status: TERMINATED ·Phase: PHASE2
-
Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
NCT05922124 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection
NCT06051513 ·Status: RECRUITING ·Phase: NA
-
Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia
NCT00786305 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa Bacteraemia
NCT05210439 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia
NCT01356472 ·Status: UNKNOWN ·Phase: PHASE4
-
Colistin Versus Colistin Plus Fosfomycin for Infections Caused by MDR Acinetobacter Baumannii
NCT01297894 ·Status: UNKNOWN ·Phase: PHASE3
-
Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital
NCT05862402 ·Status: UNKNOWN ·Phase: PHASE4
-
Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections
NCT05942157 ·Status: RECRUITING ·Phase: NA